Cancer Types | |
Supportive Care |
More Topics |
All Topics 
|
ONCOLOGY Vol 18 No 14
-
-
Epidermal Growth Factor Receptor Inhibitors and Colorectal Cancer
-
Gemcitabine and Paclitaxel in Metastatic Breast Cancer: A Review
-
Irinotecan and Other Agents in the Management of Multiple Tumor Types
-
Gemcitabine in Combination With Trastuzumab and/or Platinum Salts in Breast Cancer Cells With HER2 Overexpression
-
Irinotecan and 5-FU/ Leucovorin in Metastatic Colorectal Cancer: Balancing Efficacy, Toxicity, and Logistics
-
Adjuvant Chemotherapy for Early-Stage Breast Cancer: The tAnGo Trial
-
Are We Overtreating Some Patients With Rectal Cancer?
-
Pharmacology, Pharmacokinetics, and Practical Applications of Bortezomib
-
Integrating Gemcitabine Into Breast Cancer Therapy
-
Concurrent RT With 5-FU/Epirubicin and Cisplatin or Irinotecan for Locally Advanced Upper GI Adenocarcinoma
-
Commentary (Grandis/Foon): Emerging Role of EGFR-Targeted Therapies and Radiation in Head and Neck Cancer
-
Proteasome Inhibition in Hematologic Malignancies: Clinical Update and Practical Applications
-
Selecting Adjuvant Endocrine Therapy for Breast Cancer
-
Phase II Trial of Weekly Irinotecan/ Cisplatin in Advanced Esophageal Cancer
-
Are We Overtreating Some Patients With Rectal Cancer?
-
Cisplatin, Fluorouracil, Celecoxib, and RT in Resectable Esophageal Cancer: Preliminary Results
-
Long-Term Efficacy and Toxicity of the FEC100 Regimen
-
Irinotecan, Epirubicin, and Capecitabine in Metastatic Adenocarcinomas: Preliminary Results of a Phase I Study
-
Are We Overtreating Some Patients With Rectal Cancer?
-
Gemcitabine/ Irinotecan/Celecoxib in Pancreatic Cancer
-
Emerging Role of EGFR-Targeted Therapies and Radiation in Head and Neck Cancer
-
Gemcitabine and Platinum-Based Chemotherapy in Metastatic Breast Cancer
-
Discovery,Development, and Clinical Applications of Bortezomib
-
Invasive Candida Infections: The Changing Epidemiology
-
Neoadjuvant Therapy With Gemcitabine in Breast Cancer
-
Gemcitabine and Docetaxel in Metastatic Breast Cancer
-
Celecoxib and Radiation Therapy in Non–Small-Cell Lung Cancer
-
Commentary (Sartor): Emerging Role of EGFR-Targeted Therapies and Radiation in Head and Neck Cancer
-
Combined-Modality Therapy of Rectal Cancer With Irinotecan- Based Regimens
-
Selecting Adjuvant Endocrine Therapy for Breast Cancer
-
Integrating Gemcitabine Into Breast Cancer Therapy
-
Anthracycline and Trastuzumab in Breast Cancer Treatment
-
Are We Overtreating Some Patients With Rectal Cancer?
-
Selecting Adjuvant Endocrine Therapy for Breast Cancer
-
Antifungal Resistance: The Clinical Front
-
Irinotecan and Carboplatin in Metastatic or Recurrent NSCLC: An Update
|
|
|
